lunes, 14 de agosto de 2023

Aflibercept Biosimilars Show Comparability to Reference Drug in Registration Trials for nAMD and DME Ellen Kurek

https://www.medscape.com/viewarticle/aflibercept-biosimilars-show-comparability-reference-drug-2023a1000hu7?ecd=WNL_confwrap_asrs_230814_MSCPEDIT_etid5739584&uac=148436CN&impID=5739584

No hay comentarios:

Publicar un comentario